The FDA schedules an advisory panel meeting to evaluate the use of power morcellators in hysterectomy and myomectomy procedures, after the devices were linked to the spread of cancer beyond the uterus.
The FDA said today that it plans to convene an advisory panel to evaluate the use power morcellators in gynecological procedures after the devices, used to remove uterine tissue, were linked with the spread of cancer.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tY207X
Cap comentari:
Publica un comentari a l'entrada